カテゴリ： 世界, 医療/バイオ, Market Monitor Global

接合菌症治療のグローバル市場展望 2023年-2029年：抗真菌薬、手術療法、支持療法

■ 英語タイトル：Zygomycosis Treatments Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC12472）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC12472
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医療
■ ページ数：65
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[接合菌症治療のグローバル市場展望 2023年-2029年：抗真菌薬、手術療法、支持療法]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の接合菌症治療市場規模と予測を収録しています。・世界の接合菌症治療市場：売上、2018年-2023年、2024年-2029年
・世界の接合菌症治療市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の接合菌症治療市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「抗真菌薬」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

接合菌症治療のグローバル主要企業は、X-Gen Pharmaceuticals, Inc.、 Cayman Chemical、 LGM Pharma、 Astellas Pharma US, Inc.、 Gilead Sciences, Inc.、 Health Biotech Limited、 Squibb & Sons, LLC.、 VWR Life Sciences、 Lonza Walkersville Inc.などです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、接合菌症治療のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の接合菌症治療市場：タイプ別、2018年-2023年、2024年-2029年
世界の接合菌症治療市場：タイプ別市場シェア、2022年
・抗真菌薬、手術療法、支持療法

世界の接合菌症治療市場：用途別、2018年-2023年、2024年-2029年
世界の接合菌症治療市場：用途別市場シェア、2022年
・専門診療所、病院、その他

世界の接合菌症治療市場：地域・国別、2018年-2023年、2024年-2029年
世界の接合菌症治療市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における接合菌症治療のグローバル売上、2018年-2023年
・主要企業における接合菌症治療のグローバル売上シェア、2022年
・主要企業における接合菌症治療のグローバル販売量、2018年-2023年
・主要企業における接合菌症治療のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
X-Gen Pharmaceuticals, Inc.、 Cayman Chemical、 LGM Pharma、 Astellas Pharma US, Inc.、 Gilead Sciences, Inc.、 Health Biotech Limited、 Squibb & Sons, LLC.、 VWR Life Sciences、 Lonza Walkersville Inc.

*************************************************************

・調査・分析レポートの概要
接合菌症治療市場の定義
市場セグメント
世界の接合菌症治療市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の接合菌症治療市場規模
世界の接合菌症治療市場規模：2022年 VS 2029年
世界の接合菌症治療市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの接合菌症治療の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の接合菌症治療製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：抗真菌薬、手術療法、支持療法
接合菌症治療のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：専門診療所、病院、その他
接合菌症治療の用途別グローバル売上・予測

・地域別市場分析
地域別接合菌症治療市場規模 2022年と2029年
地域別接合菌症治療売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
X-Gen Pharmaceuticals, Inc.、 Cayman Chemical、 LGM Pharma、 Astellas Pharma US, Inc.、 Gilead Sciences, Inc.、 Health Biotech Limited、 Squibb & Sons, LLC.、 VWR Life Sciences、 Lonza Walkersville Inc.
...

This research report provides a comprehensive analysis of the Zygomycosis Treatments market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Zygomycosis Treatments market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Zygomycosis Treatments, challenges faced by the industry, and potential opportunities for market players.
The global Zygomycosis Treatments market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Zygomycosis Treatments market presents opportunities for various stakeholders, including Specialty Clinics, Hospitals. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Zygomycosis Treatments market. Additionally, the growing consumer demand present avenues for market expansion.
The global Zygomycosis Treatments market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Zygomycosis Treatments market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Zygomycosis Treatments market.
Market Overview: The report provides a comprehensive overview of the Zygomycosis Treatments market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Antifungal Medications, Surgical Interventions), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Zygomycosis Treatments market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Zygomycosis Treatments market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Zygomycosis Treatments market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Zygomycosis Treatments market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Zygomycosis Treatments market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Zygomycosis Treatments market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Zygomycosis Treatments, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Zygomycosis Treatments market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Zygomycosis Treatments market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Antifungal Medications
Surgical Interventions
Supportive Care
Market segment by Application
Specialty Clinics
Hospitals
Others
Global Zygomycosis Treatments Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
X-Gen Pharmaceuticals, Inc.
Cayman Chemical
LGM Pharma
Astellas Pharma US, Inc.
Gilead Sciences, Inc.
Health Biotech Limited
Squibb & Sons, LLC.
VWR Life Sciences
Lonza Walkersville Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Zygomycosis Treatments, market overview.
Chapter 2: Global Zygomycosis Treatments market size in revenue.
Chapter 3: Detailed analysis of Zygomycosis Treatments company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Zygomycosis Treatments in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Zygomycosis Treatments Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Zygomycosis Treatments Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Zygomycosis Treatments Overall Market Size
2.1 Global Zygomycosis Treatments Market Size: 2022 VS 2029
2.2 Global Zygomycosis Treatments Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Zygomycosis Treatments Players in Global Market
3.2 Top Global Zygomycosis Treatments Companies Ranked by Revenue
3.3 Global Zygomycosis Treatments Revenue by Companies
3.4 Top 3 and Top 5 Zygomycosis Treatments Companies in Global Market, by Revenue in 2022
3.5 Global Companies Zygomycosis Treatments Product Type
3.6 Tier 1, Tier 2 and Tier 3 Zygomycosis Treatments Players in Global Market
3.6.1 List of Global Tier 1 Zygomycosis Treatments Companies
3.6.2 List of Global Tier 2 and Tier 3 Zygomycosis Treatments Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Zygomycosis Treatments Market Size Markets, 2022 & 2029
4.1.2 Antifungal Medications
4.1.3 Surgical Interventions
4.1.4 Supportive Care
4.2 By Type – Global Zygomycosis Treatments Revenue & Forecasts
4.2.1 By Type – Global Zygomycosis Treatments Revenue, 2018-2023
4.2.2 By Type – Global Zygomycosis Treatments Revenue, 2024-2029
4.2.3 By Type – Global Zygomycosis Treatments Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Zygomycosis Treatments Market Size, 2022 & 2029
5.1.2 Specialty Clinics
5.1.3 Hospitals
5.1.4 Others
5.2 By Application – Global Zygomycosis Treatments Revenue & Forecasts
5.2.1 By Application – Global Zygomycosis Treatments Revenue, 2018-2023
5.2.2 By Application – Global Zygomycosis Treatments Revenue, 2024-2029
5.2.3 By Application – Global Zygomycosis Treatments Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Zygomycosis Treatments Market Size, 2022 & 2029
6.2 By Region – Global Zygomycosis Treatments Revenue & Forecasts
6.2.1 By Region – Global Zygomycosis Treatments Revenue, 2018-2023
6.2.2 By Region – Global Zygomycosis Treatments Revenue, 2024-2029
6.2.3 By Region – Global Zygomycosis Treatments Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Zygomycosis Treatments Revenue, 2018-2029
6.3.2 US Zygomycosis Treatments Market Size, 2018-2029
6.3.3 Canada Zygomycosis Treatments Market Size, 2018-2029
6.3.4 Mexico Zygomycosis Treatments Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Zygomycosis Treatments Revenue, 2018-2029
6.4.2 Germany Zygomycosis Treatments Market Size, 2018-2029
6.4.3 France Zygomycosis Treatments Market Size, 2018-2029
6.4.4 U.K. Zygomycosis Treatments Market Size, 2018-2029
6.4.5 Italy Zygomycosis Treatments Market Size, 2018-2029
6.4.6 Russia Zygomycosis Treatments Market Size, 2018-2029
6.4.7 Nordic Countries Zygomycosis Treatments Market Size, 2018-2029
6.4.8 Benelux Zygomycosis Treatments Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Zygomycosis Treatments Revenue, 2018-2029
6.5.2 China Zygomycosis Treatments Market Size, 2018-2029
6.5.3 Japan Zygomycosis Treatments Market Size, 2018-2029
6.5.4 South Korea Zygomycosis Treatments Market Size, 2018-2029
6.5.5 Southeast Asia Zygomycosis Treatments Market Size, 2018-2029
6.5.6 India Zygomycosis Treatments Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Zygomycosis Treatments Revenue, 2018-2029
6.6.2 Brazil Zygomycosis Treatments Market Size, 2018-2029
6.6.3 Argentina Zygomycosis Treatments Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Zygomycosis Treatments Revenue, 2018-2029
6.7.2 Turkey Zygomycosis Treatments Market Size, 2018-2029
6.7.3 Israel Zygomycosis Treatments Market Size, 2018-2029
6.7.4 Saudi Arabia Zygomycosis Treatments Market Size, 2018-2029
6.7.5 UAE Zygomycosis Treatments Market Size, 2018-2029
7 Zygomycosis Treatments Companies Profiles
7.1 X-Gen Pharmaceuticals, Inc.
7.1.1 X-Gen Pharmaceuticals, Inc. Company Summary
7.1.2 X-Gen Pharmaceuticals, Inc. Business Overview
7.1.3 X-Gen Pharmaceuticals, Inc. Zygomycosis Treatments Major Product Offerings
7.1.4 X-Gen Pharmaceuticals, Inc. Zygomycosis Treatments Revenue in Global Market (2018-2023)
7.1.5 X-Gen Pharmaceuticals, Inc. Key News & Latest Developments
7.2 Cayman Chemical
7.2.1 Cayman Chemical Company Summary
7.2.2 Cayman Chemical Business Overview
7.2.3 Cayman Chemical Zygomycosis Treatments Major Product Offerings
7.2.4 Cayman Chemical Zygomycosis Treatments Revenue in Global Market (2018-2023)
7.2.5 Cayman Chemical Key News & Latest Developments
7.3 LGM Pharma
7.3.1 LGM Pharma Company Summary
7.3.2 LGM Pharma Business Overview
7.3.3 LGM Pharma Zygomycosis Treatments Major Product Offerings
7.3.4 LGM Pharma Zygomycosis Treatments Revenue in Global Market (2018-2023)
7.3.5 LGM Pharma Key News & Latest Developments
7.4 Astellas Pharma US, Inc.
7.4.1 Astellas Pharma US, Inc. Company Summary
7.4.2 Astellas Pharma US, Inc. Business Overview
7.4.3 Astellas Pharma US, Inc. Zygomycosis Treatments Major Product Offerings
7.4.4 Astellas Pharma US, Inc. Zygomycosis Treatments Revenue in Global Market (2018-2023)
7.4.5 Astellas Pharma US, Inc. Key News & Latest Developments
7.5 Gilead Sciences, Inc.
7.5.1 Gilead Sciences, Inc. Company Summary
7.5.2 Gilead Sciences, Inc. Business Overview
7.5.3 Gilead Sciences, Inc. Zygomycosis Treatments Major Product Offerings
7.5.4 Gilead Sciences, Inc. Zygomycosis Treatments Revenue in Global Market (2018-2023)
7.5.5 Gilead Sciences, Inc. Key News & Latest Developments
7.6 Health Biotech Limited
7.6.1 Health Biotech Limited Company Summary
7.6.2 Health Biotech Limited Business Overview
7.6.3 Health Biotech Limited Zygomycosis Treatments Major Product Offerings
7.6.4 Health Biotech Limited Zygomycosis Treatments Revenue in Global Market (2018-2023)
7.6.5 Health Biotech Limited Key News & Latest Developments
7.7 Squibb & Sons, LLC.
7.7.1 Squibb & Sons, LLC. Company Summary
7.7.2 Squibb & Sons, LLC. Business Overview
7.7.3 Squibb & Sons, LLC. Zygomycosis Treatments Major Product Offerings
7.7.4 Squibb & Sons, LLC. Zygomycosis Treatments Revenue in Global Market (2018-2023)
7.7.5 Squibb & Sons, LLC. Key News & Latest Developments
7.8 VWR Life Sciences
7.8.1 VWR Life Sciences Company Summary
7.8.2 VWR Life Sciences Business Overview
7.8.3 VWR Life Sciences Zygomycosis Treatments Major Product Offerings
7.8.4 VWR Life Sciences Zygomycosis Treatments Revenue in Global Market (2018-2023)
7.8.5 VWR Life Sciences Key News & Latest Developments
7.9 Lonza Walkersville Inc.
7.9.1 Lonza Walkersville Inc. Company Summary
7.9.2 Lonza Walkersville Inc. Business Overview
7.9.3 Lonza Walkersville Inc. Zygomycosis Treatments Major Product Offerings
7.9.4 Lonza Walkersville Inc. Zygomycosis Treatments Revenue in Global Market (2018-2023)
7.9.5 Lonza Walkersville Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Zygomycosis Treatments Market Opportunities & Trends in Global Market
Table 2. Zygomycosis Treatments Market Drivers in Global Market
Table 3. Zygomycosis Treatments Market Restraints in Global Market
Table 4. Key Players of Zygomycosis Treatments in Global Market
Table 5. Top Zygomycosis Treatments Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Zygomycosis Treatments Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Zygomycosis Treatments Revenue Share by Companies, 2018-2023
Table 8. Global Companies Zygomycosis Treatments Product Type
Table 9. List of Global Tier 1 Zygomycosis Treatments Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Zygomycosis Treatments Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Zygomycosis Treatments Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Zygomycosis Treatments Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Zygomycosis Treatments Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Zygomycosis Treatments Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Zygomycosis Treatments Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Zygomycosis Treatments Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Zygomycosis Treatments Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Zygomycosis Treatments Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Zygomycosis Treatments Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Zygomycosis Treatments Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Zygomycosis Treatments Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Zygomycosis Treatments Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Zygomycosis Treatments Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Zygomycosis Treatments Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Zygomycosis Treatments Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Zygomycosis Treatments Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Zygomycosis Treatments Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Zygomycosis Treatments Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Zygomycosis Treatments Revenue, (US$, Mn), 2024-2029
Table 30. X-Gen Pharmaceuticals, Inc. Company Summary
Table 31. X-Gen Pharmaceuticals, Inc. Zygomycosis Treatments Product Offerings
Table 32. X-Gen Pharmaceuticals, Inc. Zygomycosis Treatments Revenue (US$, Mn) & (2018-2023)
Table 33. X-Gen Pharmaceuticals, Inc. Key News & Latest Developments
Table 34. Cayman Chemical Company Summary
Table 35. Cayman Chemical Zygomycosis Treatments Product Offerings
Table 36. Cayman Chemical Zygomycosis Treatments Revenue (US$, Mn) & (2018-2023)
Table 37. Cayman Chemical Key News & Latest Developments
Table 38. LGM Pharma Company Summary
Table 39. LGM Pharma Zygomycosis Treatments Product Offerings
Table 40. LGM Pharma Zygomycosis Treatments Revenue (US$, Mn) & (2018-2023)
Table 41. LGM Pharma Key News & Latest Developments
Table 42. Astellas Pharma US, Inc. Company Summary
Table 43. Astellas Pharma US, Inc. Zygomycosis Treatments Product Offerings
Table 44. Astellas Pharma US, Inc. Zygomycosis Treatments Revenue (US$, Mn) & (2018-2023)
Table 45. Astellas Pharma US, Inc. Key News & Latest Developments
Table 46. Gilead Sciences, Inc. Company Summary
Table 47. Gilead Sciences, Inc. Zygomycosis Treatments Product Offerings
Table 48. Gilead Sciences, Inc. Zygomycosis Treatments Revenue (US$, Mn) & (2018-2023)
Table 49. Gilead Sciences, Inc. Key News & Latest Developments
Table 50. Health Biotech Limited Company Summary
Table 51. Health Biotech Limited Zygomycosis Treatments Product Offerings
Table 52. Health Biotech Limited Zygomycosis Treatments Revenue (US$, Mn) & (2018-2023)
Table 53. Health Biotech Limited Key News & Latest Developments
Table 54. Squibb & Sons, LLC. Company Summary
Table 55. Squibb & Sons, LLC. Zygomycosis Treatments Product Offerings
Table 56. Squibb & Sons, LLC. Zygomycosis Treatments Revenue (US$, Mn) & (2018-2023)
Table 57. Squibb & Sons, LLC. Key News & Latest Developments
Table 58. VWR Life Sciences Company Summary
Table 59. VWR Life Sciences Zygomycosis Treatments Product Offerings
Table 60. VWR Life Sciences Zygomycosis Treatments Revenue (US$, Mn) & (2018-2023)
Table 61. VWR Life Sciences Key News & Latest Developments
Table 62. Lonza Walkersville Inc. Company Summary
Table 63. Lonza Walkersville Inc. Zygomycosis Treatments Product Offerings
Table 64. Lonza Walkersville Inc. Zygomycosis Treatments Revenue (US$, Mn) & (2018-2023)
Table 65. Lonza Walkersville Inc. Key News & Latest Developments
List of Figures
Figure 1. Zygomycosis Treatments Segment by Type in 2022
Figure 2. Zygomycosis Treatments Segment by Application in 2022
Figure 3. Global Zygomycosis Treatments Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Zygomycosis Treatments Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Zygomycosis Treatments Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Zygomycosis Treatments Revenue in 2022
Figure 8. By Type - Global Zygomycosis Treatments Revenue Market Share, 2018-2029
Figure 9. By Application - Global Zygomycosis Treatments Revenue Market Share, 2018-2029
Figure 10. By Type - Global Zygomycosis Treatments Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Zygomycosis Treatments Revenue Market Share, 2018-2029
Figure 12. By Application - Global Zygomycosis Treatments Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Zygomycosis Treatments Revenue Market Share, 2018-2029
Figure 14. By Region - Global Zygomycosis Treatments Revenue Market Share, 2018-2029
Figure 15. By Country - North America Zygomycosis Treatments Revenue Market Share, 2018-2029
Figure 16. US Zygomycosis Treatments Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Zygomycosis Treatments Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Zygomycosis Treatments Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Zygomycosis Treatments Revenue Market Share, 2018-2029
Figure 20. Germany Zygomycosis Treatments Revenue, (US$, Mn), 2018-2029
Figure 21. France Zygomycosis Treatments Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Zygomycosis Treatments Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Zygomycosis Treatments Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Zygomycosis Treatments Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Zygomycosis Treatments Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Zygomycosis Treatments Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Zygomycosis Treatments Revenue Market Share, 2018-2029
Figure 28. China Zygomycosis Treatments Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Zygomycosis Treatments Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Zygomycosis Treatments Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Zygomycosis Treatments Revenue, (US$, Mn), 2018-2029
Figure 32. India Zygomycosis Treatments Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Zygomycosis Treatments Revenue Market Share, 2018-2029
Figure 34. Brazil Zygomycosis Treatments Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Zygomycosis Treatments Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Zygomycosis Treatments Revenue Market Share, 2018-2029
Figure 37. Turkey Zygomycosis Treatments Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Zygomycosis Treatments Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Zygomycosis Treatments Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Zygomycosis Treatments Revenue, (US$, Mn), 2018-2029
Figure 41. X-Gen Pharmaceuticals, Inc. Zygomycosis Treatments Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Cayman Chemical Zygomycosis Treatments Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. LGM Pharma Zygomycosis Treatments Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Astellas Pharma US, Inc. Zygomycosis Treatments Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Gilead Sciences, Inc. Zygomycosis Treatments Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Health Biotech Limited Zygomycosis Treatments Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Squibb & Sons, LLC. Zygomycosis Treatments Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. VWR Life Sciences Zygomycosis Treatments Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Lonza Walkersville Inc. Zygomycosis Treatments Revenue Year Over Year Growth (US$, Mn) & (2018-2023)



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • CDP-コリンのグローバル市場展望 2023年-2029年：注射剤、錠剤、カプセル剤
  • 治療用放射性リガンドのグローバル市場展望 2023年-2029年：ベータ線放出、標的アルファ療法
  • 安全性薬理学のグローバル市場展望 2023年-2029年：呼吸器系、中枢神経系、循環器系、医療機器安全性評価、天然物安全性評価、その他
  • ポナチニブHClのグローバル市場展望 2023年-2029年：研究用ポナチニブHCl、診断用ポナチニブHCl
  • リポソームナノキャリア薬剤のグローバル市場展望 2023年-2029年：リポソーム医薬品、脂質ナノ粒子医薬品
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23DC12472 )"接合菌症治療のグローバル市場展望 2023年-2029年：抗真菌薬、手術療法、支持療法" (英文：Zygomycosis Treatments Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。